Stay updated on Belantamab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab in Multiple Myeloma Clinical Trial page.

Latest updates to the Belantamab in Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.3.3 was added, and the footer item for 'HHS Vulnerability Disclosure' as well as the old 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedDifference0.8%

- Check33 days agoChange DetectedThe page history now shows Revision v3.3.2, replacing the previous Revision v3.2.0.SummaryDifference0.1%

- Check40 days agoChange DetectedThe government funding/operating status notice at the top of the page was removed. This change affects only banner text and does not alter the study data or history records.SummaryDifference0.6%

- Check54 days agoChange DetectedVersion 16 (2025-06-04) is added to the Record History with a Study Status update; the rest of the history list remains consistent with prior entries.SummaryDifference0.1%

- Check83 days agoChange Detected- Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).SummaryDifference12%

Stay in the know with updates to Belantamab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab in Multiple Myeloma Clinical Trial page.